Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah King

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Vaccine|June 6, 2020
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in GuineaYap Boum, Aitana Juan-Giner, Matt Hitchings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy VolunteersMyron M Levine, Salim Abdullah, Yaseen M Arabi, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 29, 2024
Safer and targeted use of antipsychotics in youth: an embedded, pragmatic randomized trialRobert B Penfold, Abisola E Idu, R Yates Coley, et al.
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
The Lancet. Microbe|May 19, 2025
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern AfricaChama Chanda, Freddie Kibengo, Michael Mutua, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Frontiers in Immunology|June 10, 2017
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensSven Kratochvil, Paul F McKay, Jakub T Kopycinski, et al.
Vaccine|June 6, 2020
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in GuineaYap Boum, Aitana Juan-Giner, Matt Hitchings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy VolunteersMyron M Levine, Salim Abdullah, Yaseen M Arabi, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 29, 2024
Safer and targeted use of antipsychotics in youth: an embedded, pragmatic randomized trialRobert B Penfold, Abisola E Idu, R Yates Coley, et al.
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
The Lancet. Microbe|May 19, 2025
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern AfricaChama Chanda, Freddie Kibengo, Michael Mutua, et al.
Pageof 5